查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1598813

疫苗管瓶监测器市场：按类型、应用分类 - 2025-2030 年全球预测

Vaccine Vial Monitor Market by Type (Multi-Dose, Single Dose), Application (Preventive Vaccine, Therapeutic Vaccine) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 189 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年疫苗管瓶监测器市值为2.2425亿美元，预计2024年将达到2.7538亿美元，复合年增长率为22.89%，到2030年将达到9.4927亿美元。

疫苗管瓶监测器 (VVM) 是放置在疫苗管瓶上的小型设备，透过改变颜色来指示疫苗是否受热影响，进而影响功效。对监测卡的需求源于维持疫苗分发中的低温运输以确保维持疫苗功效的至关重要性。无论是在已开发国家还是开发中国家，维持最佳储存条件是一项挑战。最终用户通常包括医疗保健提供者、医院、诊所和政府免疫计划。 VVM 市场的成长受到疫苗宣传活动的增加、对疫苗功效重要性的认识不断提高以及监测敏感性技术进步的影响。此外，全球政府和非政府对免疫计画的支持不断增加也支撑了需求。然而，VVM 技术的高成本以及某些地区对其优势的认识有限等挑战可能会影响市场扩张。此外，广泛使用此类监视器需要依赖一致的供应链，而该供应链在不利条件下可能会中断。

主要市场统计
基准年[2023] 2.2425亿美元
预测年份 [2024] 27538万美元
预测年份 [2030] 9.4927 亿美元
复合年增长率（%） 22.89%

有机会将 VVM 的应用扩展到其他温度敏感药物，并增加开拓市场的采用，特别是在医疗基础设施薄弱的地区。公司可以透过开发支援即时监控和资料登录的数位整​​合监测卡来创新并支援更好地管理疫苗分销网路。探索成本更低但同样有效的监测卡材料有助于降低製造成本并使监测卡更容易获得。竞争是 VVM 市场的本质，科技公司和医疗保健提供者有合作增强设备能力的空间。公司可以透过投资培训计划来提高相关人员的知识并利用伙伴关係关係来加强销售管道，从而实现策略扩张。

市场动态：针对快速发展的疫苗管瓶监测器市场揭示的关键市场见解

供需因素的动态交互作用正在改变疫苗管瓶监测器市场。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 疫苗安全管理的需求与重要性
    • 需要适当监测疫苗管瓶
    • 感染疾病高发生率及加大疫苗接种力度
  • 市场限制因素
    • 应用和物流问题
  • 市场机会
    • 疫苗管瓶监控器与低温运输基础设施之间的关係
    • 医疗卫生部门加大力度提升偏远地区医疗服务便利度
  • 市场挑战
    • VVM 的谨慎监管考虑

波特的五力：驾驭疫苗管瓶监测器市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解疫苗管瓶监测器市场的外部影响

外部宏观环境因素在塑造疫苗管瓶监测器市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助企业预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解疫苗管瓶监测器市场的竞争状况

疫苗管瓶监视器市场的详细市场占有率分析可以对供应商的业绩进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵疫苗管瓶监视器市场供应商的绩效评估

FPNV 定位矩阵是评估疫苗管瓶监测器市场供应商的关键工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议绘製疫苗管瓶监测器市场的成功之路

对于旨在加强在全球市场的影响力的公司来说，对疫苗管瓶监测仪市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 疫苗接种的需求与安全使用的重要性
      • 需要适当监测疫苗管瓶
      • 感染疾病传播加剧及疫苗接种推广工作
    • 抑制因素
      • 应用和物流相关问题
    • 机会
      • 疫苗管瓶监控器与低温运输基础设施之间的关係
      • 加强医疗卫生领域工作，提高偏远地区医疗服务可近性
    • 任务
      • VVM 的严格监管考虑
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章疫苗管瓶监测器市场：依类型

  • 多剂量
  • 单一剂量

第七章疫苗管瓶监测器市场：依应用分类

  • 预防性疫苗
  • 治疗性疫苗

第八章北美和南美疫苗管瓶监测仪市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第九章亚太疫苗管瓶监测仪市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十章欧洲、中东和非洲疫苗管瓶监测仪市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十一章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Cardinal Health, Inc.
  • Catalent, Inc.
  • Corning Incorporated
  • DWK Life Sciences GmbH
  • Elitech Technology, Inc.
  • ELPRO-BUCHS AG
  • EVIGENCE SENSORS Inc.
  • Gerresheimer AG
  • Lisaline Lifescience Technologies Pvt Ltd.
  • Nipro Corporation
  • Pacific Vial Manufacturing Inc.
  • Schott AG
  • Stevanato Group
  • Temptime Corporation by Zebra Technologies Corporation
  • Thermo Fisher Scientific Inc.
Product Code: MRR-FB6C9E792F4C

The Vaccine Vial Monitor Market was valued at USD 224.25 million in 2023, expected to reach USD 275.38 million in 2024, and is projected to grow at a CAGR of 22.89%, to USD 949.27 million by 2030.

Vaccine Vial Monitors (VVMs) are small devices attached to vaccine vials that change color to indicate whether the vaccine has been exposed to heat, thus affecting its potency. The need for VVMs stems from the critical requirement to maintain the cold chain in vaccine distribution to ensure vaccines remain effective. Their application is essential in both developed and developing regions, where maintaining optimal storage conditions is challenging. End-users predominantly include healthcare providers, hospitals, clinics, and government immunization programs. The growth of the VVM market is influenced by increasing vaccination campaigns, rising awareness on the importance of vaccine potency, and technological advancements in monitor sensitivity. Additionally, growing governmental and non-governmental support for immunization programs globally has driven demand. However, challenges such as the high cost of VVM technology and limited awareness about their benefits in some regions may affect market expansion. There is also a reliance on consistent supply chains to ensure the widespread availability of such monitors, which can be disrupted in adverse conditions.

KEY MARKET STATISTICS
Base Year [2023] USD 224.25 million
Estimated Year [2024] USD 275.38 million
Forecast Year [2030] USD 949.27 million
CAGR (%) 22.89%

Opportunities exist in expanding the application of VVMs to other temperature-sensitive pharmaceuticals and increasing penetration in untapped markets, particularly in regions with weaker healthcare infrastructures. Companies can innovate by developing VVMs with digital integration to allow real-time monitoring and data logging, which would support better management of vaccine distribution networks. Research into lower-cost but equally effective materials for VVMs may aid in reducing manufacturing costs, making them more accessible. The nature of the VVM market is competitive, with room for collaboration between tech firms and healthcare providers to enhance device features. Businesses can strategically expand by investing in training programs to improve stakeholder knowledge and by leveraging partnerships to strengthen distribution channels, catering particularly to regions with extreme temperature conditions where the demand for VVMs is crucial.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Vaccine Vial Monitor Market

The Vaccine Vial Monitor Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Demand for administration and importance to the safe use of the vaccines
    • Need for adequate monitoring of vaccine vials
    • High prevalence of infectious diseases and a growing number of initiatives to promote immunization
  • Market Restraints
    • Issues associated with applications, and logistics
  • Market Opportunities
    • Relationship between vaccine vial monitors and cold chain infrastructure
    • Increasing healthcare sector efforts towards improving accessibility of medical services in remote areas
  • Market Challenges
    • Stingent regulatory consideration for VVM

Porter's Five Forces: A Strategic Tool for Navigating the Vaccine Vial Monitor Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Vaccine Vial Monitor Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Vaccine Vial Monitor Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Vaccine Vial Monitor Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Vaccine Vial Monitor Market

A detailed market share analysis in the Vaccine Vial Monitor Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Vaccine Vial Monitor Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Vaccine Vial Monitor Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Vaccine Vial Monitor Market

A strategic analysis of the Vaccine Vial Monitor Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Vaccine Vial Monitor Market, highlighting leading vendors and their innovative profiles. These include Cardinal Health, Inc., Catalent, Inc., Corning Incorporated, DWK Life Sciences GmbH, Elitech Technology, Inc., ELPRO-BUCHS AG, EVIGENCE SENSORS Inc., Gerresheimer AG, Lisaline Lifescience Technologies Pvt Ltd., Nipro Corporation, Pacific Vial Manufacturing Inc., Schott AG, Stevanato Group, Temptime Corporation by Zebra Technologies Corporation, and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Vaccine Vial Monitor Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Multi-Dose and Single Dose.
  • Based on Application, market is studied across Preventive Vaccine and Therapeutic Vaccine.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Demand for administration and importance to the safe use of the vaccines
      • 5.1.1.2. Need for adequate monitoring of vaccine vials
      • 5.1.1.3. High prevalence of infectious diseases and a growing number of initiatives to promote immunization
    • 5.1.2. Restraints
      • 5.1.2.1. Issues associated with applications, and logistics
    • 5.1.3. Opportunities
      • 5.1.3.1. Relationship between vaccine vial monitors and cold chain infrastructure
      • 5.1.3.2. Increasing healthcare sector efforts towards improving accessibility of medical services in remote areas
    • 5.1.4. Challenges
      • 5.1.4.1. Stingent regulatory consideration for VVM
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Vaccine Vial Monitor Market, by Type

  • 6.1. Introduction
  • 6.2. Multi-Dose
  • 6.3. Single Dose

7. Vaccine Vial Monitor Market, by Application

  • 7.1. Introduction
  • 7.2. Preventive Vaccine
  • 7.3. Therapeutic Vaccine

8. Americas Vaccine Vial Monitor Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Vaccine Vial Monitor Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Vaccine Vial Monitor Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Cardinal Health, Inc.
  • 2. Catalent, Inc.
  • 3. Corning Incorporated
  • 4. DWK Life Sciences GmbH
  • 5. Elitech Technology, Inc.
  • 6. ELPRO-BUCHS AG
  • 7. EVIGENCE SENSORS Inc.
  • 8. Gerresheimer AG
  • 9. Lisaline Lifescience Technologies Pvt Ltd.
  • 10. Nipro Corporation
  • 11. Pacific Vial Manufacturing Inc.
  • 12. Schott AG
  • 13. Stevanato Group
  • 14. Temptime Corporation by Zebra Technologies Corporation
  • 15. Thermo Fisher Scientific Inc.

LIST OF FIGURES

  • FIGURE 1. VACCINE VIAL MONITOR MARKET RESEARCH PROCESS
  • FIGURE 2. VACCINE VIAL MONITOR MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS VACCINE VIAL MONITOR MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS VACCINE VIAL MONITOR MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES VACCINE VIAL MONITOR MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES VACCINE VIAL MONITOR MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC VACCINE VIAL MONITOR MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC VACCINE VIAL MONITOR MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA VACCINE VIAL MONITOR MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA VACCINE VIAL MONITOR MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. VACCINE VIAL MONITOR MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. VACCINE VIAL MONITOR MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. VACCINE VIAL MONITOR MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. VACCINE VIAL MONITOR MARKET DYNAMICS
  • TABLE 7. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY MULTI-DOSE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY SINGLE DOSE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY PREVENTIVE VACCINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY THERAPEUTIC VACCINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. AMERICAS VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 14. AMERICAS VACCINE VIAL MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 15. AMERICAS VACCINE VIAL MONITOR MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 16. ARGENTINA VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 17. ARGENTINA VACCINE VIAL MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 18. BRAZIL VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 19. BRAZIL VACCINE VIAL MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 20. CANADA VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 21. CANADA VACCINE VIAL MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 22. MEXICO VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 23. MEXICO VACCINE VIAL MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 24. UNITED STATES VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 25. UNITED STATES VACCINE VIAL MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 26. UNITED STATES VACCINE VIAL MONITOR MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 27. ASIA-PACIFIC VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. ASIA-PACIFIC VACCINE VIAL MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 29. ASIA-PACIFIC VACCINE VIAL MONITOR MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 30. AUSTRALIA VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. AUSTRALIA VACCINE VIAL MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 32. CHINA VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. CHINA VACCINE VIAL MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 34. INDIA VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. INDIA VACCINE VIAL MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. INDONESIA VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. INDONESIA VACCINE VIAL MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 38. JAPAN VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. JAPAN VACCINE VIAL MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. MALAYSIA VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. MALAYSIA VACCINE VIAL MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 42. PHILIPPINES VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. PHILIPPINES VACCINE VIAL MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. SINGAPORE VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. SINGAPORE VACCINE VIAL MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. SOUTH KOREA VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. SOUTH KOREA VACCINE VIAL MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. TAIWAN VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. TAIWAN VACCINE VIAL MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. THAILAND VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. THAILAND VACCINE VIAL MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. VIETNAM VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. VIETNAM VACCINE VIAL MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. EUROPE, MIDDLE EAST & AFRICA VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. EUROPE, MIDDLE EAST & AFRICA VACCINE VIAL MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. EUROPE, MIDDLE EAST & AFRICA VACCINE VIAL MONITOR MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 57. DENMARK VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. DENMARK VACCINE VIAL MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. EGYPT VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. EGYPT VACCINE VIAL MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. FINLAND VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. FINLAND VACCINE VIAL MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. FRANCE VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. FRANCE VACCINE VIAL MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. GERMANY VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. GERMANY VACCINE VIAL MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. ISRAEL VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. ISRAEL VACCINE VIAL MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. ITALY VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. ITALY VACCINE VIAL MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. NETHERLANDS VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. NETHERLANDS VACCINE VIAL MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. NIGERIA VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. NIGERIA VACCINE VIAL MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. NORWAY VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. NORWAY VACCINE VIAL MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. POLAND VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. POLAND VACCINE VIAL MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. QATAR VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. QATAR VACCINE VIAL MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. RUSSIA VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. RUSSIA VACCINE VIAL MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. SAUDI ARABIA VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. SAUDI ARABIA VACCINE VIAL MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. SOUTH AFRICA VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH AFRICA VACCINE VIAL MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. SPAIN VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. SPAIN VACCINE VIAL MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. SWEDEN VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. SWEDEN VACCINE VIAL MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. SWITZERLAND VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. SWITZERLAND VACCINE VIAL MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. TURKEY VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. TURKEY VACCINE VIAL MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. UNITED ARAB EMIRATES VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. UNITED ARAB EMIRATES VACCINE VIAL MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED KINGDOM VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED KINGDOM VACCINE VIAL MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. VACCINE VIAL MONITOR MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 100. VACCINE VIAL MONITOR MARKET, FPNV POSITIONING MATRIX, 2023